Pharmaceutical Industry Information Portal

HomeTagsAntibodies

All posts by tag

Antibodies

Startup RQ Biotechnology received $157 million from AstraZeneca for Covid antibodies

RQ Bio emerges from stealth mode announcing its launch as a new UK-based biotechnology company following the completion of a successful licensing deal with...

New study shows, longer intervals between COVID-19 vaccinations result in 9 times more protective antibodies

New research has shown that a longer interval between primary COVID-19 vaccine doses can boost antibody production up to nine-fold. The study currently being presented at...

China advances commercialisation of long-acting COVID neutralising antibody therapy

TSB Therapeutics, the holding company of Brii Bio, and Sinopharm have entered into a strategic collaboration to commercialize Brii Bio's long-acting neutralizing monoclonal antibody...

Sanofi and IGM Biosciences collaborate to develop IgM antibody agonists

Sanofi and IGM Biosciences, Inc. today announced the signing of an exclusive worldwide collaboration agreement to create, develop, manufacture, and commercialize IgM antibody agonists...

Henlius received the approval of innovative monoclonal antibody of patients with advanced unresectable MSI-H

Henlius Biotech, Inc. announced that its first self-developed innovative PD-1 inhibitor HANSIZHUANG (generic name: serplulimab injection) has been approved by the National Medical Products...

Taiwan OBI Pharma enters license agreement with China Odeon Therapeutics

OBI Pharma, Inc. and Odeon Therapeutic, the biopharma companies, have entered into an exclusive license agreement whereby OBI grants rights of OBI-999, a novel...
spot_img

Expert Articles

spot_img